These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20640898)

  • 1. Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging.
    Yabuuchi H; Matsuo Y; Sunami S; Kamitani T; Kawanami S; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Tokunaga E; Yamamoto H; Honda H
    Eur Radiol; 2011 Jan; 21(1):11-7. PubMed ID: 20640898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study.
    Wu LM; Chen J; Hu J; Gu HY; Xu JR; Hua J
    Acta Radiol; 2014 Feb; 55(1):24-31. PubMed ID: 23878358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings.
    Bickelhaupt S; Tesdorff J; Laun FB; Kuder TA; Lederer W; Teiner S; Maier-Hein K; Daniel H; Stieber A; Delorme S; Schlemmer HP
    Eur Radiol; 2017 Feb; 27(2):562-569. PubMed ID: 27193776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
    Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
    J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-resolution, 3-D diffusion-weighted imaging in the detection of breast cancer compared to dynamic contrast-enhanced magnetic resonance imaging.
    Yadav P; Harit S; Kumar D
    Pol J Radiol; 2021; 86():e277-e286. PubMed ID: 34136045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the differential diagnosis of benign and malignant breast lesions using a deep learning model based on multimodal images.
    Du Y; Wang D; Liu M; Zhang X; Ren W; Sun J; Yin C; Yang S; Zhang L
    J Cancer Res Ther; 2024 Apr; 20(2):625-632. PubMed ID: 38687933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
    Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
    J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
    Daimiel Naranjo I; Lo Gullo R; Saccarelli C; Thakur SB; Bitencourt A; Morris EA; Jochelson MS; Sevilimedu V; Martinez DF; Pinker-Domenig K
    Eur Radiol; 2021 Jan; 31(1):356-367. PubMed ID: 32780207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncontrast-Enhanced MR-Based Conductivity Imaging for Breast Cancer Detection and Lesion Differentiation.
    Suh J; Kim JH; Kim SY; Cho N; Kim DH; Kim R; Kim ES; Jang MJ; Ha SM; Lee SH; Chang JM; Moon WK
    J Magn Reson Imaging; 2021 Aug; 54(2):631-645. PubMed ID: 33894088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.
    Liu Y; Jia X; Zhao J; Peng Y; Yao X; Hu X; Cui J; Chen H; Chen X; Wu J; Hong N; Wang S; Wang Y
    J Magn Reson Imaging; 2024 Aug; 60(2):600-612. PubMed ID: 37933890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images.
    Kanao S; Kataoka M; Iima M; Ikeda DM; Toi M; Togashi K
    Magn Reson Imaging; 2018 Jul; 50():38-44. PubMed ID: 29545213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.